What should I pay attention to in my diet while taking Pralsetinib?
Pralsetinib is an oral selective RET kinase inhibitor mainly used to treat patients with RET gene fusion-positive non-small cell lung cancer and thyroid cancer. During the medication period, reasonable dietary management can help enhance the therapeutic effect, reduce side effects, and improve the patient's overall quality of life. Therefore, patients should pay attention to several key dietary considerations while taking platinib.
Platinib may cause gastrointestinal effects such as nausea, diarrhea, and decreased appetite. To reduce these symptoms, patients should avoid eating foods that are too greasy, spicy, or pungent and choose a diet that is easy to digest, light, and rich in nutrients. In addition, eating small amounts over multiple times can help relieve gastrointestinal discomfort and avoid the digestive burden caused by eating too much at one time.
Platinib may affect liver function, and patients should limit alcohol intake to avoid increasing the burden on the liver. Also, avoid taking medications or supplements that may damage your liver, such as certain herbal products. In your diet, you should consume more fruits and vegetables rich in antioxidants, such as blueberries, spinach, etc., to support liver health.
Be careful to avoid drug interactions with certain foods or drinks when taking your medication. The metabolism of platinib mainly depends on the CYP3A enzyme system of the liver. Certain citrus fruits (such as grapefruit) may inhibit CYP3A activity, leading to an increase in drug blood concentration and an increased risk of adverse reactions. Therefore, patients should avoid concurrent ingestion of grapefruit and its products.
Overall, dietary management during platinib treatment should focus on protecting the digestive system, maintaining liver function, and avoiding drug interactions. Patients should develop a personalized diet plan based on the recommendations of doctors and nutritionists to ensure nutritional balance, minimize adverse reactions, and promote treatment effects.
Reference materials:https://gavreto.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)